Fairvalue-Calculator Fairvalue-Calculator
EN DE

Lapidoth-Heletz Limited (LPHL) Fair Value & Analysis

Energy · Il · Market cap 96.8M ILA

Price1.34 ILA
Fair Value1.23 ILA
Upside-8.2%
Quality95/100
Evidence: Medium Range 0.9200 ILA – 1.54 ILA

Fair value as of: Jun 24, 2026

Analysis

Lapidoth-Heletz Limited (LPHL) currently trades at 1.34 ILA, while our model-based Fair Value estimate is 1.23 ILA — implying the stock looks roughly 8.2% overvalued today. We read business quality at 95/100 (high quality), in the Energy sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Lapidoth-Heletz Limited Partnership engages in the exploration and production of oil and gas properties in Israel. The company was founded in 2004 and is based in Or Yehuda, Israel. Lapidoth-Heletz Limited Partnership is a subsidiary of Lapidoth Capital Ltd.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Lapidoth-Heletz Limited (LPHL) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1.23 ILA versus a price of 1.34 ILA — about −8% (overvalued). Model-based estimate, not financial advice.
What is the fair value of LPHL?
Our 21-model fair value for Lapidoth-Heletz Limited is 1.23 ILA (as of Jun 24, 2026), built from audited fundamentals. The current price is 1.34 ILA.
What is the quality score of LPHL?
Lapidoth-Heletz Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.